Comparative Efficacy of Insulin and Alternative Therapies for Hypertriglyceridemia-Associated Acute Pancreatitis: A Systematic Review and Network Meta-Analysis.
Alejandro Chen Liang, Yeison Cruz Castillo, Lorena M Murrieta Bruciaga et al.
✦ AI-curated · Sources linked
In 30 seconds
This systematic review and network meta-analysis evaluated the efficacy of insulin and alternative therapies for hypertriglyceridemia-associated acute pancreatitis. The study found no significant superiority of any intervention over insulin for mortality, organ failure, or length of stay. Notably, therapeutic plasma exchange significantly reduced triglyceride levels compared to insulin (MD -620.0; p=0.03).
Key findings
- No intervention showed significant superiority over insulin for mortality or organ failure.
- Therapeutic plasma exchange reduced triglyceride levels significantly compared to insulin (MD -620.0; p=0.03).
- Insulin plus heparin was associated with a shorter hospital stay (MD -1.60 days; p<0.01).
- Rapid triglyceride reduction did not consistently improve clinical outcomes.
Why it matters
Understanding the comparative efficacy of treatments for hypertriglyceridemia-associated acute pancreatitis is crucial for optimizing patient management. Clinicians need to be aware that biochemical improvements may not translate into better clinical outcomes.
What to keep in mind
Most evidence was derived from observational studies, and the certainty of evidence was predominantly low or very low.